CompletedNCT04453280

Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity)

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institute of Health Information and Statistics of the Czech Republic
Principal Investigator
Roman Prymula, Prof.
Ministry of Health, Czech Republic
Intervention
Quantitative analysis of anti-SARS-CoV-2-antibodies(diagnostic_test)
Enrollment
695 target
Eligibility
8 years · All sexes
Timeline
20202020

Study locations (1)

Collaborators

Ministry of Health, Czech Republic · Masaryk University · Institute for Clinical and Experimental Medicine · Brno University Hospital · St. Anne's University Hospital Brno, Czech Republic · Masaryk Memorial Cancer Institute · Regional Public Health Office of the South Moravian Region based in Brno, Czech Republic · Public Health Office of the Capital City of Prague, Czech Republic · Regional Public Health Office of the Central Bohemian Region based in Prague, Czech Republic

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04453280 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials